Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease—a single center case series
Efrat Luttwak, David Hagin, Chava Perry, Ofir Wolach, Gilad Itchaki, Odelia Amit, Yael Bar‐On, Tal Freund, Sigi Kay, Rinat Eshel, Irit Avivi, Ron Ram
Topics & Concepts
MedicineRituximabImmunophenotypingChimeric antigen receptorLymphoproliferative disordersSalvage therapyLymphomaImmunologyRefractory (planetary science)Hematopoietic stem cell transplantationTransplantationInternal medicineOncologyT cellChemotherapyAntigenImmune systemPhysicsAstrobiologyCAR-T cell therapy researchLymphoma Diagnosis and TreatmentPolyomavirus and related diseases